Signant Health expands availability of its eClinical solutions by joining IQVIA One Home for Sites initiative

Core Insights - Signant Health has joined IQVIA's One Home for Sites initiative, aimed at simplifying clinical trial site operations through a unified platform [1][2] Group 1: Initiative Overview - The One Home for Sites initiative is designed to streamline site conduct by allowing clinical research staff to access multiple eClinical technologies from various providers through a single sign-on [2] - Signant's SmartSignals® Unified Platform will be integrated into the One Home for Sites platform, offering a comprehensive solution that includes eCOA, EDC, RTSM, eConsent, and telemedicine [3] Group 2: Company Perspectives - Signant's Chief Product Officer expressed satisfaction with the integration of their Unified Platform into the initiative, highlighting the alignment with their strategy to provide a single access point for all products [4] - IQVIA's VP of Commercialization emphasized the collaborative nature of the initiative and welcomed Signant's contribution to enhancing the clinical trial ecosystem for all stakeholders, particularly patients [4] Group 3: Company Background - Signant Health specializes in evidence generation for clinical studies, leveraging software and operational expertise to provide solutions for remote and site-based clinical trials [5] - IQVIA is a global leader in clinical research services and healthcare intelligence, employing approximately 88,000 individuals across over 100 countries to support the development of innovative medical treatments [6]